Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2018-09-17 M&A Activity
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC AND ALMIRALL ENTER INTO RESEARCH COLLABORATION IN THE FIELD OF DERMATOLOGICAL DISEASES
M&A Activity Classification · 99% confidence The document is a press release dated September 17, 2018, announcing a research collaboration between Evotec AG and Almirall S.A. regarding dermatological diseases. It contains key highlights, quotes from management, and boilerplate information about both companies. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a general corporate announcement regarding a business development/partnership. Since there is no specific category for 'Partnership Announcement' or 'Business Development,' and it is not a short announcement pointing to a separate report (ruling #2), the most appropriate general category is 'Regulatory Filings' (RNS), which serves as the fallback for miscellaneous corporate news that doesn't fit the highly specific categories provided.
2018-09-17 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' as per German securities law (WpHG). It reports a change in the percentage of voting rights held by DWS Investment GmbH in Evotec AG, crossing a threshold (from 5.02% to 4.92%). This directly corresponds to the definition of reporting changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a specific notification of a major holding change, making MRQ more precise than DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2018-09-11 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by BlackRock, Inc. in Evotec AG, referencing specific German securities laws (WpHG Sections 33, 34, 38). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The code for this category is MRQ.
2018-09-06 English
EVOTEC AG LISTED IN MDAX
Regulatory Filings Classification · 100% confidence The document is a short news release dated September 6, 2018, announcing that Evotec AG's shares will be included in the MDAX index starting September 24, 2018. This is a specific corporate action announcement related to stock market indices and listing status, not a comprehensive financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a general corporate announcement disseminated via DGAP. Since it doesn't fit the specific categories like DIRS, DIV, or CAP, and it is a formal announcement, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news that doesn't fit other specific types. Given the nature of the announcement (index inclusion), it is a material event disclosure.
2018-09-06 English
EVOTEC AND CELGENE ENTER PARTNERSHIP IN THE FIELD OF TARGETED PROTEIN DEGRADATION
Regulatory Filings Classification · 100% confidence The document is a press release dated September 6, 2018, announcing a new strategic drug discovery and development partnership between Evotec AG and Celgene Corporation regarding targeted protein degradation. It details the focus, the platforms being leveraged (Panomics, PanHunter), and the financial terms (upfront payment, milestones, royalties). This type of announcement, which details a significant business development, partnership, or strategic agreement, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a general corporate news item disseminated via DGAP. Since it is not a specific financial report, a management change, a dividend notice, or a shareholder vote result, the most appropriate general category for significant, non-standard corporate news is 'Regulatory Filings' (RNS), which serves as the fallback for miscellaneous regulatory announcements that don't fit elsewhere, especially when disseminated through a service like DGAP.
2018-09-06 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' by BlackRock, Inc. in Evotec AG, referencing specific German securities law articles (WpHG). This type of filing reports changes in significant share ownership thresholds. This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory announcement disseminated via DGAP, the specific content dictates the classification over the general 'RNS' fallback.
2018-09-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.